The Europe glucose monitoring system CGMS market is predicted to grow at a CAGR of 23.00%, and the SMBG market is estimated to record a CAGR of 5.40% over the estimated period of 2019-2028. The growing awareness about integrating digital technology, and advanced CGM devices to monitor and manage glucose levels, are some of the major factors contributing to market growth in the region.
EUROPE GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028
Europe Glucose Monitoring System Market by Component Type (Sensors, Transmitters and Receivers, Insulin Pump) by End-users (Home Settings, Diagnostics and Clinics, Hospitals) by Demographics (Adult Population (>14years), Child Population (≤14years)) by Component Type (Test Strips, Glucose Meter, Lancets) by End-user (Home Settings, Clinical, Hospital) by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) by Geography.
The Europe glucose monitoring system CGMS market is predicted to grow at a CAGR of 23.00%, and the SMBG market is estimated to record a CAGR of 5.40% over the estimated period of 2019-2028. The growing awareness about integrating digital technology, and advanced CGM devices to monitor and manage glucose levels, are some of the major factors contributing to market growth in the region.
To know more about this report, request a free sample copy
The Europe glucose monitoring system market is surveyed further by dividing the region into respective countries such as Russia, Italy, Germany, Poland, France, Belgium, the UK, and the rest of Europe. Germany has a multilayered healthcare system, funded by statutory contributions ensuring free healthcare for all. The types of insurance in the country are law-enforced health insurance and private insurance. Germany is one of the largest pharmaceutical markets in Europe with a volume of over $xx billion, though showing only moderate growth of 5% per annum. The UK has about 3.5 million people with diabetes, which is expected to rise to 5 million by 2025. The total health expenditure per capita has recently fallen. There are private health insurance and various alternative treatments available apart from the public systems.
France has established a universal health insurance system, largely financed by government national health insurance. Most of the chronic diseases are 100% covered by the French statutory health insurance. The pharmaceutical market is the second-largest in Europe after Germany, growing at 2% per annum. The health ministry has granted national reimbursement for FreeStyle Libre, Abbott’s glucose monitoring technology. Such factors are beneficial for market growth.
Braun Melsungen AG is one of the world’s largest manufacturers and providers of healthcare solutions, headquartered in Melsungen, Germany. The product portfolio comprises 5,000 different products, of which, 95% is manufactured by the company. In September 2019, B.Braun and Philips launched Onvision needle tip tracking, a significant achievement for regional anesthesia.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARIES
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
- RISE IN THE INCIDENCE OF DIABETES
- INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
- TECHNOLOGY INTEGRATION
- INCREASING CGMS AND SMBG AFFORDABILITY
- TECHNOLOGICAL ADVANCES IN GMS DEVICES
- AWARENESS AMONG THE GENERAL POPULATION
- KEY RESTRAINTS
- HINDRANCE FROM GOVERNMENT REGULATIONS
- INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
- LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
- INTENSE COMPETITION AMONG VENDORS
- INACCURACY IN READING OF GMS DEVICES
- KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
- THREAT OF NEW ENTRY
- THREAT OF SUBSTITUTION
- BUYER’S POWER
- SUPPLIER’S POWER
- COMPETITIVE RIVALRY
- KEY BUYING CRITERIA
- REGULATION OF BLOOD SUGAR
- VALUE CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- CGMS MARKET BY COMPONENT TYPE
- SENSORS
- TRANSMITTER AND RECEIVERS
- INTEGRATED INSULIN PUMPS
- CGMS MARKET BY END-USER
- HOME SETTINGS
- DIAGNOSTICS AND CLINICAL
- HOSPITAL
- CGMS MARKET BY DEMOGRAPHICS
- ADULT POPULATION (>14YEARS)
- CHILD POPULATION (≤14YEARS)
- SMBG MARKET OVERVIEW
- SMBG MARKET BY COMPONENT TYPE
- TEST STRIPS
- GLUCOSE METER
- LANCETS
- SMBG MARKET BY END-USER
- HOME SETTINGS
- CLINICAL
- HOSPITAL
- SMBG MARKET BY APPLICATION
- TYPE 1 DIABETES
- TYPE 2 DIABETES
- GESTATIONAL DIABETES
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- GERMANY HEALTH AND HEALTHCARE
- GERMANY PHARMACEUTICAL MARKET
- THE UNITED KINGDOM
- THE UNITED KINGDOM HEALTH AND HEALTHCARE
- THE UNITED KINGDOM HEALTHCARE PROVISION
- THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
- THE UNITED KINGDOM PHARMACEUTICALS
- FRANCE
- FRANCE HEALTH AND HEALTHCARE
- FRANCE HEALTHCARE PROVISION
- RUSSIA
- RUSSIA HEALTH AND HEALTHCARE
- RUSSIA PHARMACEUTICAL SERVICES
- ITALY
- ITALY HEALTH AND HEALTHCARE
- ITALY HEALTHCARE PROVISION
- ITALY PHARMACEUTICAL MARKET
- BELGIUM
- POLAND
- REST OF EUROPE (ROE)
- GERMANY
- EUROPE
- COMPANY PROFILES
- ABBOTT
- APEX BIOTECHNOLOGY CORPORATION
- ARKRAY INC
- ASCENSIA
- B BRAUN MELSUNGEN AG
- BECTON DICKINSON AND COMPANY
- DEXCOM
- GLYSENS INC
- INSULET CORP
- I-SENS INC
- JOHNSON AND JOHNSON
- MEDTRONIC
- MOREPEN LABORATORIES LTD
- NEMAURA MEDICAL INC
- ROCHE DIAGNOSTICS
- SENSEONICS INC
- TANDEM DIABETES CARE
- TERUMO
- WOCKHARDT
- YPSOMED
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – GLUCOSE MONITORING SYSTEM
TABLE 2: DIABETES PREVALENCE IN EUROPE 2015-2040 (MILLIONS)
TABLE 3: EUROPE CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: EUROPE CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: EUROPE CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: EUROPE CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: EUROPE CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: EUROPE CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 10: PRODUCT MATRIX FOR LANCETS
TABLE 11: EUROPE SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: EUROPE SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: EUROPE SMBG MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: EUROPE SMBG MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: EUROPE SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: EUROPE SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: EUROPE CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: EUROPE CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: EUROPE SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: EUROPE SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 22: GERMANY SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 23: AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 24: THE UNITED KINGDOM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: VALUE CHAIN OF CGMS MARKET
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY INVESTMENT INSIGHTS
FIGURE 6: EUROPE CGMS MARKET, BY COMPONENT TYPE, IN 2019
FIGURE 7: EUROPE CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE CGMS MARKET, BY END-USER, IN 2019
FIGURE 11: EUROPE CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
FIGURE 12: EUROPE CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE CGMS MARKET, BY DEMOGRAPHICS, IN 2019
FIGURE 15: EUROPE CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)
FIGURE 16: EUROPE CGMS MARKET, BY CHILD POPULATION (≤14YEARS), 2019-2028 (IN $ MILLION)
FIGURE 17: EUROPE SMBG MARKET, BY COMPONENT TYPE, IN 2019
FIGURE 18: EUROPE SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)
FIGURE 19: EUROPE SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)
FIGURE 20: EUROPE SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)
FIGURE 21: EUROPE SMBG MARKET, BY END-USER, IN 2019
FIGURE 22: EUROPE SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
FIGURE 23: EUROPE SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)
FIGURE 24: EUROPE SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
FIGURE 25: EUROPE SMBG MARKET, BY APPLICATION, IN 2019
FIGURE 26: EUROPE SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 27: EUROPE SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 28: EUROPE SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)
FIGURE 29: EUROPE CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 30: EUROPE SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 31: GERMANY CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 32: GERMANY SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 33: THE UNITED KINGDOM CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 34: THE UNITED KINGDOM SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 35: FRANCE CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 36: FRANCE SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 37: RUSSIA CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 38: RUSSIA SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 39: ITALY CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 40: ITALY SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 41: BELGIUM CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 42: BELGIUM SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 43: POLAND CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 44: POLAND SMBG MARKET, 2019-2028 (IN $ MILLION)
FIGURE 45: REST OF EUROPE CGMS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 46: REST OF EUROPE SMBG MARKET, 2019-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- GERMANY HEALTH AND HEALTHCARE
- GERMANY PHARMACEUTICAL MARKET
- THE UNITED KINGDOM
- THE UNITED KINGDOM HEALTH AND HEALTHCARE
- THE UNITED KINGDOM HEALTHCARE PROVISION
- THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
- THE UNITED KINGDOM PHARMACEUTICALS
- FRANCE
- FRANCE HEALTH AND HEALTHCARE
- FRANCE HEALTHCARE PROVISION
- RUSSIA
- RUSSIA HEALTH AND HEALTHCARE
- RUSSIA PHARMACEUTICAL SERVICES
- ITALY
- ITALY HEALTH AND HEALTHCARE
- ITALY HEALTHCARE PROVISION
- ITALY PHARMACEUTICAL MARKET
- BELGIUM
- POLAND
- REST OF EUROPE (ROE)
- GERMANY
- CGMS MARKET BY COMPONENT TYPE
- SENSORS
- TRANSMITTER AND RECEIVERS
- INTEGRATED INSULIN PUMPS
- CGMS MARKET BY END-USER
- HOME SETTINGS
- DIAGNOSTICS AND CLINICAL
- HOSPITAL
- CGMS MARKET BY DEMOGRAPHICS
- ADULT POPULATION (>14YEARS)
- CHILD POPULATION (≤14YEARS)
- SMBG MARKET OVERVIEW
- SMBG MARKET BY COMPONENT TYPE
- TEST STRIPS
- GLUCOSE METER
- LANCETS
- SMBG MARKET BY END-USER
- HOME SETTINGS
- CLINICAL
- HOSPITAL
- SMBG MARKET BY APPLICATION
- TYPE 1 DIABETES
- TYPE 2 DIABETES
- GESTATIONAL DIABETES
- EUROPE
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.